苏州迈泰生物技术有限公司

Metabomics, Inc. (苏州迈泰生物技术有限公司www.metabomics.com) is an innovativepharmaceutical R&D company with a revolutionary technology platformto address an unmet need in drug R&D, where a key bottleneck is thelack of efficient technology to transform rationally designed newchemical entities (NCEs), which often possess high in vitro activity butwith poor in vivo properties, into a more natural-product like scaffoldwith improved Absorption, Distribution, Metabolism, Excretion andToxicity (ADMET) profile.

The company is a Sino-US joint venture dedicated to development ofgreen, low-carbon, cost-efficient, high throughput and scalablebiotechnology to allow our customers and partners to access to diverseand unconventional Medicinal Chemistry space, and to map out themetabolic pathways of NCEs or drugs in animals, humans and the environment.

The company is located in Zhangjiagang, one of the best cities in humansettlement suitability, Jiangsu province. Its leadership team is builtwith true expertise across all aspects of drug discovery, processresearch and development and a deep understanding of how to build andoperate high quality professional services organizations. It hasestablished close cooperation relationships with global customers.